Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George P Biro

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Drug Discovery Technologies|July 6, 2011
Adverse HBOC-endothelial dysfunction synergism: a possible contributor to adverse clinical outcomes?George P Biro
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|February 27, 2003
The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogsDavid Wicks, Lawrence T Wong, Reena Sandhu, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|June 1, 2010
Reassessing the risk of hemodilutional anemia: Some new pieces to an old puzzleAlbert K Y Tsui, Neil D Dattani, Philip A Marsden, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Drug Discovery Technologies|July 6, 2011
Adverse HBOC-endothelial dysfunction synergism: a possible contributor to adverse clinical outcomes?George P Biro
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|February 27, 2003
The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogsDavid Wicks, Lawrence T Wong, Reena Sandhu, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|June 1, 2010
Reassessing the risk of hemodilutional anemia: Some new pieces to an old puzzleAlbert K Y Tsui, Neil D Dattani, Philip A Marsden, et al.
Pageof 1